Open Extension Study Evaluating the Safety and Tolerability of Oral Ziprasidone in the Treatment of Subjects Who Have Successfully Completed a Previous Ziprasidone Study.

Trial Profile

Open Extension Study Evaluating the Safety and Tolerability of Oral Ziprasidone in the Treatment of Subjects Who Have Successfully Completed a Previous Ziprasidone Study.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Aug 2010

At a glance

  • Drugs Ziprasidone (Primary)
  • Indications Schizophrenia
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 13 Jul 2010 Actual end date added to 1 Jun 2009 as reported by ClinicalTrials.gov.
    • 13 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Jun 2009 Actual patient number changed from 329 to 344 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top